Platelia SARS-CoV-2 Total Ab Assay

Manufactured by Bio-Rad Laboratories Inc., United States - www.bio-rad.com/ 

Related Scientific Literature

• Diagnostics for SARS-CoV-2 detection: A comprehensive review of the FDA-EUA COVID-19 testing landscape
• Current and Perspective Diagnostic Techniques for COVID-19
• Molecular and Immunological Diagnostic Tests of COVID-19: Current Status and Challenges
• Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence
• Testing For SARS-CoV-2: The Day the World Turned its Attention to the Clinical Laboratory
• How should diagnostic kits development adapt quickly in COVID 19-like pandemic models? Pros and cons of sensory platforms used in COVID-19 sensing
• Comparison of different serological assays for SARS-CoV-2 in real life
• Trends and Innovations in Biosensors for COVID-19 Mass Testing
• Meta-analysis of the clinical performance of commercial SARS-CoV-2 nucleic acid, antigen and antibody tests up to 22 August 2020
• Testing-on-a-probe biosensors reveal association of early SARS-CoV-2 total antibodies and surrogate neutralizing antibodies with

The database contains publicly available In Vitro Diagnostic Medical Devices for COVID-19 and it is being updated periodically. Please note that additional performance (as retrieved from manufacturers web pages) is provided only for devices commercially available with CE-IVD mark. Acknowledgements